Is Valium Better Than Xanax for Anxiety?

Neither Valium (diazepam) nor Xanax (alprazolam) is universally better for anxiety. Head-to-head clinical trials consistently show that the two drugs produce similar levels of anxiety relief, with one trial even finding alprazolam slightly more effective on several measures. The real differences lie elsewhere: how long the drug lasts in your body, how it feels during daily use, and what happens when you try to stop taking it. Those practical differences matter far more than raw potency when choosing between the two.

What Head-to-Head Trials Actually Show

The most direct way to compare two drugs is to test them against each other in blinded studies where neither the patient nor the doctor knows who is getting which pill. Several trials have done exactly this with alprazolam and diazepam. A 28-day double-blind trial found that alprazolam at roughly 1.5 to 3 mg per day was equivalent in anxiety reduction to diazepam at 15 to 30 mg per day, with some evidence that alprazolam also helped with depressive symptoms in patients who had both anxiety and depression, while diazepam did not.¹

Another trial using the same doses and duration went a step further. Alprazolam outperformed placebo on all five rating scales used and, on several of those measures, outperformed diazepam as well. Patients in the alprazolam group also reported fewer side effects, and those side effects decreased over the course of the study, while the rate in the diazepam group stayed flat.² That said, these were relatively small studies with specific patient groups, and the advantage for alprazolam was not enormous. The takeaway from the controlled literature is that both drugs work, and where they differ it tends to be on dimensions other than pure anxiety relief.

Generalized Anxiety Versus Panic Attacks

Anxiety is not one condition. The two most common forms that get treated with benzodiazepines are generalized anxiety disorder, where worry and tension are chronic and broad, and panic disorder, where sudden intense surges of fear strike without warning. The two drugs have carved out somewhat different reputations in treating these.

Diazepam has strong evidence for generalized anxiety. In one trial comparing it to placebo, diazepam produced significantly more relief starting in the first week and maintained that advantage through six weeks.³ A separate study confirmed that at six weeks of treatment, diazepam was the only drug still showing a clear separation from placebo in a generalized anxiety population.⁴

Alprazolam, on the other hand, became one of the go-to medications for panic disorder. Clinical evidence shows it directly blocks panic attacks, with rapid improvement in panic frequency, though improvements in the avoidance behaviors that build up around panic were more variable.⁵ In a comparison with the antidepressant imipramine, alprazolam showed improvement by the first or second week, while imipramine took about four weeks to kick in, though both ended up at similar effectiveness by week eight.⁶

This does not mean diazepam cannot be used for panic or alprazolam for generalized anxiety. Both work for both. But if you hear a doctor say one is “better” than the other, they are usually talking about a specific type of anxiety, and the match between drug and condition matters more than the drug in isolation.

The Half-Life Difference and Why It Shapes Everything

The single biggest pharmacological difference between these two drugs is how long they stick around in your body. Diazepam has a very long half-life, typically somewhere in the range of 20 to 100 hours, and it produces an active breakdown product that lingers even longer. Alprazolam has a much shorter half-life, roughly 6 to 12 hours, and its metabolites are not clinically active in the same way.

This distinction sounds dry, but it has cascading practical effects. With diazepam, one or two doses per day can provide relatively steady coverage. With alprazolam, you need to dose more frequently, often three times a day, because the drug wears off between doses. That wearing-off can itself trigger mini-withdrawals: brief spikes in anxiety between pills that patients sometimes mistake for their underlying condition getting worse. It is one reason some people feel more “dependent” on alprazolam even early in treatment.

The long half-life of diazepam also means it builds up in your body over days of use. That buildup is a double-edged situation. On one hand, it smooths out the drug’s effect and avoids the rollercoaster of short-acting drugs. On the other, it can lead to excessive sedation, especially during the first week or two of treatment before you reach a steady state, and it takes much longer to fully clear your system after you stop.

Sedation and Daytime Impairment

Both drugs make you drowsy, especially at first. But the pattern of impairment differs. A study measuring psychomotor performance found that after a week of regular dosing, diazepam at 15 mg per day was significantly more sedating than alprazolam at 0.75 mg per day and impaired psychomotor performance to a greater degree. Diazepam also interfered more with learning on complex tasks. Even after both drugs were stopped, diazepam showed more lingering impairment on objective tests, with measurable effects still present three days after the last dose.⁷

There was an interesting wrinkle in that study: during the follow-up period after stopping, subjects reported feeling more sedated and clumsy after alprazolam than after diazepam on self-rating scales, even though their objective performance was actually better. This discrepancy might reflect the subjective discomfort of alprazolam wearing off more abruptly, making the contrast between “on” and “off” more noticeable even when actual function is less impaired.

For people who need to drive, operate equipment, or stay mentally sharp during the day, the sedation profile matters. Diazepam’s longer duration means more sustained grogginess, particularly in the first weeks of treatment. Alprazolam tends to cause a sharper but shorter period of sedation after each dose, with clearer windows in between.

Withdrawal and Dependence

This is the area where the two drugs diverge most dramatically, and where the choice between them can have the biggest consequences. Both are habit-forming. Both will produce a withdrawal syndrome if you take them regularly and then stop suddenly. But the nature of that withdrawal is not the same.

Short-acting benzodiazepines like alprazolam tend to produce more intense withdrawal symptoms, and those symptoms can start earlier. Rebound anxiety, the temporary surge of anxiety that overshoots your original baseline, is more common when stopping a short-acting drug.⁸ This fits the broader pattern documented in the withdrawal literature: withdrawal symptoms appear to be more severe with short-acting benzodiazepines and with higher doses.⁹

Alprazolam has attracted particular concern on this front. A review of its addiction potential concluded that its withdrawal may be more severe and can develop after a shorter period of regular use compared to diazepam. The review flagged alprazolam as deserving “special caution” because of its popularity, its reinforcing properties, and the relative severity of its withdrawal syndrome.¹⁰ Both drugs enter the brain quickly after absorption, which contributes to their reinforcing effects, but the shorter half-life of alprazolam means the brain experiences more frequent cycles of drug-on and drug-off, which is the pattern most associated with dependence.

Ironically, diazepam’s long half-life, which causes more daytime sedation, is exactly what makes it gentler to taper off. Because it leaves the body slowly, the brain has more time to adjust. This is why clinicians who need to wean a patient off alprazolam will sometimes switch them to diazepam first and then gradually reduce the diazepam dose. The long tail acts as a built-in taper.

What Happens in Overdose

Benzodiazepines taken alone are relatively hard to die from compared to older sedatives like barbiturates, but they are not without risk, especially when mixed with other substances. And the two drugs are not equally forgiving. A study of over 2,000 hospital admissions for single-benzodiazepine overdoses found that alprazolam overdoses led to significantly worse outcomes than diazepam or other benzodiazepine overdoses. Patients who took too much alprazolam stayed in the hospital about 27 percent longer, were roughly twice as likely to need intensive care, and were more likely to require mechanical ventilation.¹¹

This finding held even after adjusting for the dose taken, age, sex, time since ingestion, and whether other drugs were involved. The authors described alprazolam as “relatively more toxic” than other benzodiazepines in overdose. For anyone with a history of self-harm or suicidal thoughts, this difference can influence which drug a prescriber chooses, and it is one of the reasons many clinicians prefer diazepam or longer-acting alternatives for higher-risk patients.

Older Adults Face a Different Calculus

For people over 65, the comparison tilts in a way that neither drug comes out looking great, but diazepam looks worse. Its long-acting nature becomes a liability. A prospective study found that patients using diazepam were over three times more likely to have experienced a fall in the preceding 90 days compared with non-users and even compared with users of other benzodiazepines.¹² Long-acting benzodiazepines as a class are associated with daytime confusion, dizziness, impaired coordination, and a higher risk of fractures from falls.¹²

The same review noted evidence linking benzodiazepines to the development of dementia, with stronger associations for agents with long half-lives and for extended use.¹² This does not prove that diazepam causes dementia, and the research in this area is still debated. But for older adults, the accumulation of a long-acting drug in a body that metabolizes it more slowly is a recipe for cognitive fog, unsteadiness, and accidents. Most geriatric prescribing guidelines recommend avoiding long-acting benzodiazepines entirely in this age group.

Alprazolam has its own problems for older adults, mainly around dependence, but its shorter duration at least reduces the amount of drug circulating at any one time. The honest answer for this population is that neither drug is ideal, and prescribers are generally trying to avoid both, turning to SSRIs, buspirone, or non-drug approaches as first-line treatments for anxiety in older patients.

Drug Interactions Are Not the Same

If you take other medications, the way each drug is broken down in the liver becomes relevant. Alprazolam is mainly processed by an enzyme called CYP3A4, while diazepam is only partly processed by that enzyme and relies on additional metabolic pathways.¹³ CYP3A4 is the same enzyme targeted by a wide range of common medications, including certain antibiotics, antifungals, HIV medications, and even grapefruit juice. When another drug inhibits CYP3A4, alprazolam levels in your blood can spike, potentially causing excessive sedation or toxicity. Diazepam is somewhat less vulnerable to this particular interaction because it has alternative metabolic routes, though it is not immune.

For people who take several medications, particularly older adults on complex regimens, diazepam’s broader metabolic profile can be either an advantage or a complication depending on the specific drugs involved. This is one area where the choice between the two genuinely needs to be individualized based on what else you are taking.

Why Doctors Today Often Recommend Neither

It is worth stepping back from the head-to-head comparison to note that current treatment guidelines for anxiety disorders generally do not recommend benzodiazepines as the first option. SSRIs and SNRIs have become the standard first-line treatments for both generalized anxiety and panic disorder because they are effective over the long term and do not carry the same dependence risk. Cognitive behavioral therapy is similarly recommended as a primary approach, with comparable long-term results and no withdrawal concerns at all.

Benzodiazepines, including both diazepam and alprazolam, are typically reserved for short-term use while waiting for an SSRI to take effect, which usually takes several weeks, or for situational anxiety where you need relief for a specific event. The risk of dependence, cognitive effects, and withdrawal make long-term benzodiazepine use something most clinicians try to avoid. When a prescriber does choose one, the decision between diazepam and alprazolam often comes down to a practical judgment: how fast does the patient need relief, how long does coverage need to last, and how concerned are we about the difficulty of stopping the drug later?

How Diazepam Became the Default Taper Drug

One role where diazepam has a clear practical advantage has nothing to do with treating anxiety directly. When patients need to be weaned off any benzodiazepine, including alprazolam, diazepam is the most commonly used switching agent. Its slow exit from the body acts as a natural taper: blood levels decline gradually over days rather than crashing within hours, which smooths out the withdrawal experience. The same property that makes diazepam more sedating during treatment makes it more forgiving during discontinuation.

This practice is widely used in addiction medicine and is one of the reasons diazepam remains on the World Health Organization’s list of essential medicines despite being an older drug that many clinicians avoid for regular anxiety treatment. If you are already taking alprazolam and having trouble stopping, your doctor may suggest converting to an equivalent diazepam dose and then reducing slowly from there. The switch does not eliminate withdrawal entirely, but it tends to make the process considerably less miserable than trying to taper alprazolam directly.

The Abuse Liability Question

Both drugs produce dose-dependent increases in sedation and in subjective feelings of “liking,” which is how researchers measure the reinforcing quality of a substance.¹⁴ In experimental settings, both diazepam and alprazolam rank among the most reinforcing benzodiazepines, meaning they are the ones people are most likely to want to take again.¹⁰ Neither is a safe bet for someone with a history of substance use problems.

That said, alprazolam’s rapid onset and short duration create a more intense cycle of reward and loss, which is the pharmacokinetic pattern most associated with compulsive use across nearly every drug class. This is part of why alprazolam consistently shows up as one of the most commonly misused benzodiazepines in substance abuse surveillance data, and why some prescribers are more cautious about prescribing it to patients with any history of addiction. Diazepam is not safe from misuse either, but its smoother pharmacokinetic curve makes the rewarding “hit” less sharp.